Navigation Links
Pitt phage hunter takes on tuberculosis

One third of the world's people are infected with tuberculosis, and someone new is infected every second. TB is notoriously hard to treat, requiring a course of multiple antibiotics over six to nine months. Many people don't complete the full course of treatment, which leads to increasing antibiotic resistance against the disease.

More effective treatments could be on the way, however, with a new five-year, $2.8 million grant from the National Institutes of Health to Graham Hatfull, Eberly Family Professor of Biotechnology and Chair of the Department of Biological Sciences in the University of Pittsburgh's School of Arts and Sciences. William Jacobs, professor of microbiology and immunology at the Albert Einstein College of Medicine, is a key collaborator. Both Hatfull and Jacobs are supported by the Howard Hughes Medical Institute.

The key to better treating tuberculosis, they believe, may lie in a harmless cousin of TB called Mycobacterium smegmatis. In the cover story of the December 2005 issue of Cell, Hatfull and Jacobs described how M. smegmatis forms a drug-resistant coating called a biofilm.

The researchers made this discovery by infecting M. smegmatis with a bacteriophage nicknamed the "Bronx Bomber," which Jacobs had isolated from his back yard, and which Hatfull has studied extensively. They found that when infected by the Bomber, the germ could no longer form its protective coatings. Furthermore, this occurred because the phage had disrupted a M. smegmatis gene called groEL1-which has a nearly identical counterpart in M. tuberculosis.

The NIH grant will allow Hatfull and Jacobs to explore whether the Bomber also affects the groEL1 gene in the TB-causing germ. If so, it could pave the way for medications that similarly break down the bacteria's defenses and thereby increase the effectiveness of antibiotics.

"We'd like to have an understanding of M. tuberculosis and what happens during an infection that lead s to such difficult, prolonged treatment," said Hatfull, who also codirects the Pittsburgh Bacteriophage Institute.

"An ideal scenario would be to develop drugs that would allow TB to be treated over a much shorter period of time," he added. "Shortening the treatment would lead not only to more effective and simple control of the disease, but also would cut down on the development of drug-resistant organisms."


Source:University of Pittsburgh

Related biology news :

1. Basis for DNA ejection from single phage particles
2. UCSB researchers discover shape matters to macrophages
3. Macrophage signaling may affect hormone resistance in prostate tumors
4. Study shows big game hunters, not climate change, killed off sloths
5. Good times ahead for dinosaur hunters, according to U of Penn scientists dinosaur census
6. Gene hunters close in on Lou Gehrig’s disease
7. NJIT Presidential Award winner takes stem cell research another step
8. Unique library of plant genes germinates, takes root at UNC
9. New influenza vaccine takes weeks to mass produce
10. Oops! Researchers publish new findings on the brains response to costly mistakes
11. Blood flow in brain takes a twist, affecting views of Alzheimers
Post Your Comments:

(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/9/2016)... 9, 2016 Paris Police ... video security solution to ensure the safety of people and ... during the major tournament Teleste, an international technology ... services, announced today that its video security solution will be ... back up public safety across the country. The system roll-out ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
Breaking Biology Technology: